Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06455072
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cervical Cancer |
Keywords: